Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure. 1988

C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
Department of Medicine, Medical School, University of Newcastle upon Tyne.

To examine the association between hyperoxalaemia and secondary oxalosis, measurement of plasma oxalate concentration was combined with a search for tissue deposition of calcium oxalate crystals in patients with chronic renal disease. Two groups of patients were studied. In the first, samples of the inferior epigastric artery were taken from 35 patients at the time of renal transplantation. In the second, sections taken at necropsy from 23 patients with chronic renal failure in whom plasma oxalate had been measured before death were examined. Though plasma oxalate concentrations ranged between 6 and 116 mumol/l (four to 78 times greater than the upper limit of the reference range), no extrarenal deposits of oxalate were found in either study. Renal deposition of oxalate was associated with a plasma oxalate concentration of greater than 20 mumol/l. This study gives no support to the suggestion that hyperoxalaemia of the degree seen in patients with the type of chronic renal failure that is not due to primary hyperoxaluria confers an appreciable risk of extrarenal oxalosis.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010070 Oxalates Derivatives of OXALIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are derived from the ethanedioic acid structure. Oxalate,Ethanedioic Acids,Oxalic Acids,Acids, Ethanedioic,Acids, Oxalic
D002129 Calcium Oxalate The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi. Calcium Oxalate (1:1),Calcium Oxalate Dihydrate,Calcium Oxalate Dihydrate (1:1),Calcium Oxalate Monohydrate,Calcium Oxalate Monohydrate (1:1),Calcium Oxalate Trihydrate,Dihydrate, Calcium Oxalate,Monohydrate, Calcium Oxalate,Oxalate, Calcium,Trihydrate, Calcium Oxalate
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
January 1990, Skeletal radiology,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
September 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
October 1974, Bulletin of the Hospital for Joint Diseases,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
January 1980, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
July 1995, Kidney international,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
October 1980, The New England journal of medicine,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
June 1982, Zeitschrift fur Urologie und Nephrologie,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
January 1992, Mineral and electrolyte metabolism,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
January 1986, Clinica chimica acta; international journal of clinical chemistry,
C R Tomson, and S M Channon, and I S Parkinson, and A R Morley, and T W Lennard, and N R Parrott, and M F Laker
February 1985, European journal of clinical investigation,
Copied contents to your clipboard!